Theriva Biologics (TOVX): Volume dodolan mangsa ngarep perusahaan

Logo grafis Theriva Biologics (TOVX)

The development of Theriva Biologics, Inc. (TOVX) is independent of GDP, relying instead on test results. The organization's promising sales volume confirms this trend, where 0.00 indicates the current level. Theriva Biologics, Inc. (TOVX) is seeking ways to expose tumors to the immune system using proprietary adenoviruses. High scientific barriers protect the business, although prolonged licensing temporarily limits final profits.

Prakiraan pendapatan perusahaan: Theriva Biologics, Inc. (TOVX) kanggo 28.04.2023 - 18.11.2026

TOVX (Theriva Biologics, Inc.): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Theriva Biologics
Sampel barang Theriva Corp

The investment attractiveness of Theriva Biologics, Inc. (TOVX) depends on the success of clinical trials in oncology. This indicator reflects the real-time market consensus regarding future cash inflows from product commercialization. By analyzing the company's projected sales volumes, an investor can see the trend of expected trading turnover. For a company without commercial sales, this chart reveals stagnation risks and the unattainability of target metrics. This metric allows for the timely identification of a value trap.

Pesaing langsung

Prakiraan pendapatan perusahaan ImmunityBio Inc (IBRX)|Volume dodolan mangsa ngarep perusahaan Immunocore PLC IMCR|Janux Therapeutics Inc - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Arcus Corp RCUS|ZYME - Prakiraan pendapatan perusahaan|TNGX (tangotx.com) - Prakiraan pendapatan perusahaan|Iovance Corp (IOVA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Immatics Corp (IMTX)|Volume dodolan mangsa ngarep perusahaan XNCR|CMPX - Prakiraan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan REPL (Replimune Corp)|Prakiraan volume pendapatan perusahaan LYEL|Prakiraan volume dodolan IPHA (Innate Pharma)|Pendapatan mangsa ngarep perusahaan PYXS|Compugen Limited - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan IO Biotech Inc.|Sutro Biopharma, Inc. (STRO) - Prakiraan pendapatan perusahaan|MiNK Therapeutics, Inc. - Pendapatan mangsa ngarep perusahaan|HOWL (Werewolf) - Prakiraan volume dodolan|Prakiraan volume dodolan immixbio.com|Prakiraan pendapatan perusahaan ALX Oncology Holdings (ALXO)|CUE - Volume dodolan sing dikarepake perusahaan|PDS Biotechnology Corporation - Volume dodolan mangsa ngarep perusahaan|Sonnet BioTherapeutics (SONN) - Volume dodolan sing dikarepake perusahaan|MAIA - Prakiraan pendapatan perusahaan|LIMN: Prakiraan pendapatan perusahaan|LVTX: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan NextCure, Inc. (NXTC)|LPTX (Leap Tx) - Prakiraan volume dodolan|INTS (Intensity Therapeutics) - Prakiraan volume pendapatan perusahaan|Prakiraan pendapatan perusahaan Sensei Bio (SNSE)|Prakiraan volume pendapatan perusahaan GRTS|Kineta Bio - Volume dodolan mangsa ngarep perusahaan|NEXI - Volume dodolan mangsa ngarep perusahaan|TSBX: Volume dodolan mangsa ngarep perusahaan|VCNX (Vaccinex, Inc.) - Prakiraan pendapatan perusahaan|Harpoon Tx (HARP) - Prakiraan pendapatan perusahaan